ARL6IP5 and breast carcinoma: Ye et al identified that low expression levels of JWA inhibited the RAF proto-oncogene serine/threonine-protein kinase (c-Raf)/MEK/ERK signaling pathway in MCF-7 breast cancer cells (14,19).